Transcriptional inhibition of the estrogen response element by antiestrogenic piperidinediones correlates with intercalation into DNA measured by energy calculations.
The energy of interaction of antiestrogenic ligands bound to DNA derived from molecular modeling was compared to the capacity of the ligands to directly inhibit the transcriptional activity of an estrogen responsive gene. 3-Phenylacetylamino-2,6-piperidinedione (A10) and related compounds were intercalated into a partially unwound DNA site in a canonical estrogen response element (ERE). The piperidinedione/ERE complexes were subjected to energy minimization and the strength of interaction of the ligands with the DNA was measured. The ability of the ligands to inhibit transactivation was assessed using a reporter gene constructed with the ERE of the vitellogenin gene promoter (ERE(v)-tk-Luc) transiently transfected into the human estrogen receptor-positive MCF-7 breast cancer cell line. The results demonstrate a direct correlation between the calculated energetic fit of the compounds in the ERE and inhibition of ERE(v) transactivation. The order of potency of the compounds to suppress estrogen-dependent reporter gene activity was identical to that previously shown for inhibiting the growth of MCF-7 cells. To our knowledge, these results provide the first direct experimental evidence that the predicted fit of a class of compounds into a defined DNA binding site correlates with the ability of the compounds to modulate specific gene functions regulated at that site.
Sidell
Neil
N
Department of Gynceology and Obstetrics, Emory University School of Medicine, 1639 Pierce Drive, Atlanta, GA 30322, USA. nsidell@emory.edu
Tanmahasamut
Prasong
P
Ewing
Douglas E
DE
Hendry
Lawrence B
LB
D001943:Breast Neoplasms / Q000188:drug therapy; D045744:Cell Line, Tumor; D003198:Computer Simulation; D004247:DNA / Q000378:metabolism*; D020847:Estrogen Receptor Modulators / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007364:Intercalating Agents / Q000494:pharmacology*; D008958:Models, Molecular; D009690:Nucleic Acid Conformation; D010880:Piperidines / Q000494:pharmacology*; D020218:Response Elements / Q000502:physiology*; D013816:Thermodynamics; D014158:Transcription, Genetic / Q000187:drug effects*
D020847:Estrogen Receptor Modulators; D007364:Intercalating Agents; D010880:Piperidines; D004247:DNA